Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 01, 2005 (Vol. 25, No. 11)

Google Scholar

  • The power of google
  • The breadth of Google
I long ago gave up attempting to review the many tools that have been around forever and are used by most scientists regularly, such as PubMed, because it's hard to say something about them that readers don't already know. New entries are fair game, however, and that is the case with Google Scholar. Google Scholar attempts to do in a very Google kind of way what PubMed does while adding a little hook to it. The results are a bit of a mixed bag. On the Plus side, the Googlishness of the site provides users users broader access than they get out of PubMed. I could, for example, retrieve a textbook that I published out of Google Scholar that is invisible on PubMed. On the other hand, PubMed had references that Google either didn't know or didn't place near the top of the rankings (this IS Google, after all). Bottom line--Google Scholar is a site whose primary virtue seems to be as a complement to PubMed, not a replacement.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »